iBio, Inc. IBIO
0.80 USD 0.00 (-0.11%)
Regular-session close
0.76 -0.04 -4.87%
After hours · Nov 20, 4:58 PM ET
0.7626 Day range 0.8266
0.71 52-week range 3.07
- YTD
- -58.54%
- 1 year
- -19.99%
News
benzinga.com iBio Presents New Preclinical Data Across Obesity and Cardiometabolic Portfolio At PEGS Europe 2026 And Amylin-Based Therapeutics Summit ObesityWeek 2026 data from obese non-human primates showed sustained Activin E suppression and a 2.3% vehicle-adjusted reduction in body weight from baseline with IBIO-610 at week 28.Amylin program…
globenewswire.com iBio Announces New Preclinical Data Across Obesity and Cardiometabolic Portfolio at Multiple Scientific Conferences ObesityWeek 2026 data from obese non-human primates showed sustained Activin E suppression and a 2.3% vehicle-adjusted reduction in body weight from baseline with IBIO-610 at week 28.benzinga.com iBio Q1 EPS $(0.05) Beats $(0.08) Estimate, Sales $1.075M Beat $20.000K Estimate iBio (AMEX:IBIO) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.08) by 37.5 percent. This is a 54.55 percent increase over losses of $(0.11) per share…
benzinga.com Alpha Buying: 3 Beaten-Down Biotech Stocks Backed by a Specialist Investor There are parts of the stock market where I am comfortable doing the research myself.Give me a community bank’s balance sheet, loan portfolio, and deposit information, and I can usually figure out…
